C066-4939 Screening compound: N-(3,4-dichlorophenyl)-6-methyl-4-(piperidin-1-yl)-N-propylfuro[2,3-d]pyrimidine-5-carboxamide

C066-4939 Screening compound: N-(3,4-dichlorophenyl)-6-methyl-4-(piperidin-1-yl)-N-propylfuro[2,3-d]pyrimidine-5-carboxamide
C066-4939 Screening compound: N-(3,4-dichlorophenyl)-6-methyl-4-(piperidin-1-yl)-N-propylfuro[2,3-d]pyrimidine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C066-4939
N-(3,4-dichlorophenyl)-6-methyl-4-(piperidin-1-yl)-N-propylfuro[2,3-d]pyrimidine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C066-4939

Molecular Formula

C22H24Cl2N4O2 (C22 H24 Cl2 N4 O2)

Compound Name

N-(3,4-dichlorophenyl)-6-methyl-4-(piperidin-1-yl)-N-propylfuro[2,3-d]pyrimidine-5-carboxamide

IUPAC name

N-(34-dichlorophenyl)-6-methyl-4-(piperidin-1-yl)-N-propylfuro[23-d]pyrimidine-5-carboxamide

SMILES

CCCN(C(c1c(C)oc2ncnc(N3CCCCC3)c12)=O)c(cc1)cc(Cl)c1Cl

InChI

InChI=1S/C22H24Cl2N4O2/c1-3-9-28(15-7-8-16(23)17(24)12-15)22(29)18-14(2)30-21-19(18)20(25-13-26-21)27-10-5-4-6-11-27/h7-8,12-13H,3-6,9-11H2,1-2H3

InChI Key

ZKDSTTGSAOSXBS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14716079

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.36

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.969

Distribution Coefficient, logD

5.969

Water Solubility, LogSw

-6.45

Polar Surface Area

47.155

Acid Dissociation Constant (pKa)

21.95

Base Dissociation Constant (pKb)

0.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

C066-4939 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C066-4939 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C066-4939?
Check Price and Availability of C066-4939, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C066-4939 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C066-4939
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C066-4939
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C066-4939 available by request